Navigation Links
Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study
Date:7/2/2009

LITTLE SILVER, N.J., July 2 /PRNewswire/ -- Dr Daniel Goldberg, a leading New Jersey ophthalmologist is coordinating a new study to measure the effectiveness of using 5% Betadine irrigation for treatment of acute EKC -- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.

Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study. The purpose of the new study is to confirm the effectiveness of this protocol and to expand the awareness amongst eye care professionals of this inexpensive treatment for EKC.

The study is being coordinated by Dr Daniel Goldberg, Clinical Associate Professor of Ophthalmology, Drexel College of Medicine as well as committee and staff members of Atlantic Eye Physicians, in Long Branch, Little Silver, and Holmdel New Jersey. This protocol is open to ophthalmologists, US and international, who agree to follow the protocol and report clinical results thru the Betadine for EKC website (http://www.betadineforekc.com/Default.aspx ). The initial phase will be collecting data thru October 1, 2009, and it is anticipated that subsequently there will be modifications to the protocol and study design.

For more information about the new study, please visit http://www.betadineforekc.com/the-study.aspx

Information on registration is available at http://www.betadineforekc.com/submission-process.aspx

About Dr Goldberg

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery. He is a founding member of Atlantic Eye Physicians, an ophthalmology-led comprehensive eye care practice with offices at Long Branch, Little Silver, and Holmdel New Jersey. Drs Michael Su and Lisa Ortenzio at Atlantic Eye Physicians are collaborating with Dr. Goldberg on the Betadine for EKC Study.


'/>"/>
SOURCE Pasch Consulting Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Glaucoma Survey: Half Unaware of Preservative-Free Beta-Blocker, Ophthalmologists Cite Benefits of Preservative-Free Medications on Ocular Comfort and Quality of Life
2. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
3. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
4. Families Invited to Celebrate Shire Day at Boston Childrens Museum
5. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
6. Budding Young Artists Invited to Compete in 17th Annual Pier 1 Imports/UNICEF Greeting Card Contest
7. CyberKnife Centers of Miami, Palm Beach and Tampa Invited to Join M.D. Anderson Cancer Center Study
8. Kentucky-Based Sports Medicine Duo Invited to Astros Spring Training Camp
9. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
10. Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop
11. Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved ... procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list ...
(Date:3/28/2017)... ... 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ... lot to offer to the discussion of dealing with excess skin oil. “Oily skin is ... home remedies that can help remove the oily shine while keeping the skin fresh and ...
(Date:3/27/2017)... Aurora, CO (PRWEB) , ... March 27, 2017 , ... ... Dr. Mark Braasch for leading sleep apnea treatment, with or without a referral. Sleep ... the condition, which can include daytime sleepiness, morning headaches and chronic snoring. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
(Date:3/27/2017)... 27, 2017 Summary This ... Eli Lilly and its partnering interests and activities since 2010. ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ... The report will be delivered in PDF format ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology: